News
The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...
Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign aid freeze.
Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.
Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...
Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
President Trump plans to impose tariffs on pharmaceuticals and semiconductors, impacting companies like Eli Lilly and Apple.
Trump has signaled plans to impose new tariffs on pharmaceuticals and semiconductors as soon as the end of July, warning that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results